跳至主要内容
临床试验/NCT03097185
NCT03097185招募中不适用

Analysis of Graft Function Following Autologous Islet Transplantation

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2010年6月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Analysis of graft function following autologous islet transplantation

研究概览

简要总结

Analyze inflammatory markers and islet graft function through blood samples collected from subjects with chronic pancreatitis who undergo total pancreatectomy with auto islet transplantation.

详细描述

A total of 100 subjects will be enrolled in this study; 85 subjects will be enrolled from patients who are scheduled for TP-AIT and 15 subjects will be for TP alone at Baylor University Medical Center at Dallas or Baylor All Saints Medical Center at Fort Worth. The patients who are enrolled in a clinical study, named 'A phase 2/3, multicenter, randomized, double-blind, placebo-controlled, parallel assignment study to assess the efficacy and safety of reparixin in pancreatic islet auto-transplantation (REP0112, IND# 117390)', can be enrolled in this study.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with chronic pancreatitis and who are scheduled for TP alone or TP-AIT
  • Patients aged 18 or older
  • Patients are able and willing to attend required follow-up visits at Baylor

排除标准

  • Patients who are unable/unwilling to attend follow-up visits at Baylor
  • For TP-AIT subjects: Patients who have advanced stage of chronic pancreatitis. The principal investigator or co-investigators carefully review the medical charts, laboratory results and radiology department reports and determine the suitability for this study.

结局指标

主要结局

Analysis of graft function following autologous islet transplantation

时间窗: One year after transplant of islet cells.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验